New treatment option for future patients with Alzheimer’s disease

New treatment option for future patients with Alzheimer’s disease

Dementia is one of the leading causes of death in England and Wales, and an estimated 850,000 people in the UK currently live with the disease. Alzheimer’s disease, which accounts for roughly 60 – 80 % of all cases of dementia, is characterised by problems with memory – especially the short-term memory is affected negatively – which may even make it difficult to remember the names of loved ones. For this reason, scientists have been trying to find a way to improve treatments for Alzheimer’s patients for years, and hopefully, a solution is near.

What is Alzheimer’s disease?

In 1906, the German doctor Alois Alzheimer was the first to report on a patient with dementia, and the disease was since named after him. Alzheimer’s disease is the most common form of dementia, and it involves a range of symptoms of decreased cognitive abilities, such as memory loss and impaired speech in the early stages of the disease. Over time, it becomes increasingly difficult to for instance find one’s way around or to add together even small numbers. Alzheimer’s disease includes changes in the patient’s emotional life, temper and personality. For instance, a patient with Alzheimer’s might go from being patient and socially active to being passive and annoyed. Changes happen both physically and mentally, but what causes the disease? The answer is that two different types of protein accumulate in the brain.

The two types of protein called beta-amyloid and tau clump together to form plaques and tangles. Beta-amyloid affects brain cells whereas tau affects nerve cells. The first areas to be affected, i.e. the areas near the temporal lobe, are responsible for memories.

There is currently no cure for Alzheimer’s, but medications which alleviate the symptoms are available. It is, however, not possible to slow the progression of the disease. Because of this, scientists have been trying to find new treatments, and it turns out that immunotherapy could be the solution for future Alzheimer’s patients. Immunotherapy us a type of therapy where the body’s own immune system is used to fight diseases.

 

The treatment has two main purposes:

  • To strengthen the immune system’s ability to recognise and attack sick cells
  • To prevent cells from strengthening themselves

Several studies are currently trying to develop this type of treatment, and it turns out that the trial period will last until 2020. At best, immunotherapy is a very distant prospect, and therefore, we should not forget the patients who live with dementia today.

 

Sources:

  1. https://www.dementiastatistics.org/statistics-about-dementia/
  2. http://www.alzheimer.dk/viden/alzheimers-sygdom

Latest health news

All health news
Wait!
It only takes 2 minutes.
Do you want to be able to join research projects?
Free and non-binding · more than 65.000 members
Yes, sign me up!
Maybe later
Health Panel

Become a part of Health Panel

The goal of Health Panel is to improve health through research, but we need your help to do so. You can help by signing up for Health Panel and thereby possibly become a participant in research projects. We will only contact you if your health profile is consistent with a current research project. All research projects are pre-approved by the respective  Independent Ethics Committees (IEC) or Institutional Review Boards (IRB).

Create Health Profile